Efficacy and safety of sintilimab plus doxorubicin in advanced soft tissue sarcoma: A single-arm, phase II trial
Zhichao Tian(Henan Cancer Hospital), Weitao Yao(Zhengzhou University), Jiaqiang Wang(Yunnan University), Wenli Zuo(Zhengzhou University), Yonghao Yang(Army Medical University), Chao Li(Qingdao University), Xin Wang(Institute of Oceanology), Fan Zhang(Wenzhou Medical University), Po Li(Second Hospital of Nanchang), Shuping Dong(Zhengzhou University), Peng Zhang(China Astronaut Research and Training Center), Shilei Gao(Zhengzhou University)
Cited by 10
Related Papers
Breastfeeding and Ovarian Cancer Risk: a Systematic Review and Meta-analysis of 40 Epidemiological Studies
|Asian Pacific Journal of Cancer Prevention|2014|119
Association between Vitamin D Insufficiency and Elevated Serum Uric Acid among Middle-Aged and Elderly Chinese Han Women
|PLoS ONE|2013|74
The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study
|Frontiers in Immunology|2021|73
G3BP1-linked mRNA partitioning supports selective protein synthesis in response to oxidative stress
|Nucleic Acids Research|2020|68